
Scheril Murray Powell, Esq., shares a preview of her talk “International Cannabis: Trade and Supply Chain Considerations for a Global Cannabis Brand.”
For years, Congress and various veterans' advocates have been working to get Veterans Affairs to drop the obstacles blocking medical cannabis use for veterans. Now real progress is at hand and we speak with Congressman Earl Blumenauer on the work he’s been doing as well as updates on the current state of legislation related to veteran access to medical cannabis.
Scheril Murray Powell, Esq., shares a preview of her talk “International Cannabis: Trade and Supply Chain Considerations for a Global Cannabis Brand.”
Sheila Gibson, the founder of Aura IP Law, shares her insights, knowledge, and advice on cannabis IP, including emerging topics.
Gretchen Schmidt, Faculty Program Director Criminal Justice Programs & Cannabis Control at Excelsior College, discusses the graduate certificate program offered at her college.
According to a press release from the National Cannabis Industry Association (NCIA), a standalone cannabis policy reform bill was brought before the House of Representatives for a vote on Wednesday, September 25, 2019 and passed with an overwhelming bipartisan majority.
Nearly every state has to weather the argument from law enforcement about how to find and get stoned drivers off the road. But developing roadside testing devices to use for finding reliable, standardized levels of THC intoxication continues to be a slippery, moving problem with no solution in sight.
More CBD consumers means more people in the workplace unaware of the issues with CBD products and THC levels who could be putting their jobs at risk.
Two new bills creating significant legislative movement put cannabis on the road to legalization
The FDA reminds CBD makers that CBD-infused edible products are still illegal, and calls for stakeholder input to begin regulation process
Where does cannabidiol’s (CBD) legal status stand following the 2018 Farm Bill? One attorney looks at common misperceptions.
President Trump’s nominee for Attorney General, William Barr, stated in his confirmation hearing that he would not go after cannabis companies that were compliant with state laws. In a recent letter in response to written questions from various senators, Barr has put that statement in writing.
The next step in the lawsuit against the Drug Enforcement Administration (DEA) and Department of Justice (DOJ) was heard this week at the United States Court of Appeals for the Second Circuit.
We recently spoke with Eric Furman, PhD, a partner at Knobbe Martens a leading intellectual property law firm with an expansive presence in the biotech and pharmaceutical fields and deep experience in intellectual property issues relating to the cannabis industry. Here, Furman provides some insight on what cases are currently on-going and what we might expect in the future as the cannabis industry continues to expand.
Two U.S. Senators introduced legislation that would allow doctors at the VA to prescribe medical cannabis to veterans in the 31 states that have established medical-marijuana programs.
The agencies sent warning letters to several companies that the agencies say are illegally marketing unapproved products to treat opioid addiction and withdrawal.